Kvietimai teikti paraiškas:

2026 m. 

• Virtual Human Twin (VHT) Models for Cancer Research

HORIZON-MISS-2026-02-CANCER-01. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Microbiome for early cancer prediction before the onset of disease

HORIZON-MISS-2026-02-CANCER-02. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

HORIZON-MISS-2026-02-CANCER-03. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Earlier and more precise palliative care

HORIZON-MISS-2026-02-CANCER-04. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

HORIZON-MISS-2026-02-CANCER-05. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Development of a research capacity building programme on cancer with and for Ukraine

HORIZON-MISS-2026-02-CANCER-06. Opening: 10 February 2026 | Deadline(s): 15 September 2026

• Improve the Quality of Life of Older Cancer Patients

HORIZON-MISS-2026-02-CANCER-07. Opening: 10 February 2026 | Deadline(s): 15 September 2026

2027 m.

• Leveraging functional genomics to reveal novel targets for cancer treatment

HORIZON-MISS-2027-02-CANCER-01.

• Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

HORIZON-MISS-2027-02-CANCER-02.

• Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes.

HORIZON-MISS-2027-02-CANCER-03.

• Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research.

HORIZON-MISS-2027-02-CANCER-04.

• Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

HORIZON-MISS-2027-02-CANCER-05.

• Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

HORIZON-MISS-2027-02-CANCER-06.

• Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks

HORIZON-MISS-2027-06-SOIL-CANCER.

 Darbo programa:

• 2026–2027 m. darbo programa